PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-23.77%
Negative revenue growth while MAXN stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-392.47%
Negative gross profit growth while MAXN is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
44.06%
EBIT growth of 44.06% while MAXN is zero. Bruce Berkowitz would see if small gains can be scaled further.
-116.79%
Negative operating income growth while MAXN is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
43.28%
Net income growth of 43.28% while MAXN is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
43.75%
EPS growth of 43.75% while MAXN is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
43.75%
Diluted EPS growth of 43.75% while MAXN is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
0.41%
Share change of 0.41% while MAXN is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.41%
Diluted share change of 0.41% while MAXN is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-466.37%
Negative OCF growth while MAXN is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-118.25%
Negative FCF growth while MAXN is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-3.74%
Negative 10Y revenue/share CAGR while MAXN stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-56.64%
Negative 5Y CAGR while MAXN stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-12.41%
Negative 3Y CAGR while MAXN stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-65.78%
Negative 10Y OCF/share CAGR while MAXN stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-354.59%
Negative 5Y OCF/share CAGR while MAXN is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
60.99%
3Y OCF/share CAGR of 60.99% while MAXN is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
-438.19%
Negative 10Y net income/share CAGR while MAXN is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-218.94%
Negative 5Y net income/share CAGR while MAXN is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-1.70%
Negative 3Y CAGR while MAXN is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-115.11%
Negative equity/share CAGR over 10 years while MAXN stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-121.56%
Negative 5Y equity/share growth while MAXN is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-120.43%
Negative 3Y equity/share growth while MAXN is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.00%
Firm’s AR is declining while MAXN shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
8.52%
Inventory growth of 8.52% while MAXN is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-1.91%
Negative asset growth while MAXN invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-47.14%
We have a declining book value while MAXN shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
7.93%
Debt growth of 7.93% while MAXN is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
-3.72%
Our R&D shrinks while MAXN invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
16.75%
SG&A growth of 16.75% while MAXN is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.